Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

Nature Immunology

Volumn 7, Issue 2, 2006, Pages 165-172

  Wilson, Nicholas S ^a,b,c,e,f   Behrens, Georg M N ^a,e,f   Lundie, Rachel J ^a,b,c   Smith, Christopher M ^a,b,c   Waithman, Jason ^c   Young, Louise ^a,c   Forehan, Simon P ^a,c   Mount, Adele ^a,c   Steptoe, Raymond J ^d   Shortman, Ken D ^a,b   de Koning Ward, Tania F ^a   Belz, Gabrielle T ^a,b   Carbone, Francis R ^b,c   Crabb, Brendan S ^a,b   Heath, William R ^a,b   Villadangos, Jose A ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Department of Civil and Environmental Engineering   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e CSL   (Australia)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; TOLL LIKE RECEPTOR; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; DOWN REGULATION; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALARIA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SEPSIS; SPLEEN CELL; VIRUS IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CPG ISLANDS; DENDRITIC CELLS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNE TOLERANCE; LIGANDS; MALARIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PLASMODIUM BERGHEI; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 31344465638     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1300     Document Type: Article

References (51)

1. Wilson, N.S. & Villadangos, J.A. Regulation of antigen presentation and cross-presentation in the dendritic cell network: Facts, hypothesis, and immunological implications. Adv. Immunol. 86, 241-305 (2005).
2. Heath, W.R. et al. Cross-presentation dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26 (2004).
3. Sigal, L.J., Crotty, S., Andino, R. & Rock, K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80 (1999).
4. Melief, C.J. Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: Peaceful coexistence of cross-priming and direct priming? Eur. J. Immunol. 33, 2645-2654 (2003).
5. Freigang, S., Egger, D., Bienz, K., Hengartner, H. & Zinkernagel, R.M. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc. Natl. Acad. Sci. USA 100, 13477-13482 (2003).
6. Norbury, C.C. & Sigal, L.J. Cross priming or direct priming: Is that really the question? Curr. Opin. Immunol. 15, 82-88 (2003).
7. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145 (2001).
8. Garrett, W.S. et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102, 325-334 (2000).
9. West, M.A., Prescott, A.R., Eskelinen, E.L., Ridley, A.J. & Watts, C. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr. Biol. 10, 839-848 (2000).
10. West, M.A. et al. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305, 1153-1157 (2004).
11. Klinman, D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249-258 (2004).
12. Williamson, W.A. & Greenwood, B.M. Impairment of the immune response to vaccination after acute malaria. Lancet 1, 1328-1329 (1978).
13. Whittle, H.C. et al. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312, 449-450 (1984).
14. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891 (2002).
15. Urban, B.C. & Roberts, D.J. Inhibition of T cell function during malaria: Implications for immunology and vaccinology. J. Exp. Med. 197, 137-141 (2003).
16. Villadangos, J.A. & Heath, W.R. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin. Immunol. 17, 262-272 (2005).
17. Wilson, N.S. et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102, 2187-2194 (2003).
18. De Smedt, T. et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184, 1413-1424 (1996).
19. Kamath, A.T. et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165, 6762-6770 (2000).
20. + DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33, 827-833 (2003).
21. Wilson, N.S., El-Sukkari, D. & Villadangos, J.A. Dendritic cells constitutively present self antigens in their immature state in vivo, and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187-2195 (2004).
22. Villadangos, J.A., Schnorrer, P. & Wilson, N.S. Control of MHC class II antigen presentation in dendritic cells: A balance between creative and destructive forces. Immunol. Rev. 207, 191-205 (2005).
23. Brocker, T., Riedinger, M. & Karjalainen, K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but hot positive selection of thymocytes in vivo. J. Exp. Med. 185, 541-550 (1997).
24. + dendritic cells are preferentially involved in CTL priming after footpad Infection with herpes simplex virus-1. J. Immunol. 170, 4437-440 (2003).
25. + dendritic cells but not by Langerhans cells. Science 301, 1925-1928 (2003).
26. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172, 1996-2000 (2004).
27. + T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 172, 392-397 (2004).
28. Pichyangkul, S. et al. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172, 4926-4933 (2004).
29. Coban, C. et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201, 19-25 (2005).
30. Gil-Torregrosa, B.C. et al. Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34, 398-407 (2004).
31. + T cell populations lacking helper function. Nat. Immunol. 6, 163-170 (2005).
32. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592-6597 (2005).
33. Schulz, O. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887-892 (2005).
34. Urban, B.C. et al. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400, 73-77 (1999).
35. Urban, B.C., Willcox, N. & Roberts, D.J. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98, 8750-8755 (2001).
36. Ocana-Morgner, C., Mota, M.M. & Rodriguez, A. Malaria blood stage suppression of liver stage Immunity by dendritic cells. J. Exp. Med. 197, 143-151 (2003).
37. Seixas, E., Cross, C., Quin, S. & Langhorne, J. Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi. Eur. J. Immunol. 31, 2970-2978 (2001).
38. Luyendyk, J., Olivas, O.R., Ginger, L.A. & Avery, A.C. Antigen-presenting cell function during Plasmodium yoelii infection. Infect. Immun. 70, 2941-2949 (2002).
39. Leisewitz, A.L. et al. Response of the splenic dendritic cell population to malaria infection. Infect. Immun. 72, 4233-4239 (2004).
40. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787 (1997).
41. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
42. Ehst, B.D., Ingulli, E. & Jenkins, M.K. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant. 3, 1355-1362 (2003).
43. Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
44. + T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157, 978-983 (1996).
45. Mueller, S.N., Heath, W., McLain, J.D., Carbone, F.R. & Jones, C.M. Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80, 156-163 (2002).
46. Barnden, M.J., Allison, J., Heath, W.R. & Carbone, F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34-40 (1998).
47. Vremec, D., Pooley, J., Hochrein, H., Wu, L. & Shortman, K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978-2986 (2000).
48. + dendritic cells only after microbial stimulus. J. Exp. Med. 196, 1307-1319 (2002).
49. Li, M. et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166, 6099-6103 (2001).
50. Zhao, X. et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153-162 (2003).
51. Franke-Fayard, B. et al. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 137, 23-33 (2004).